Top

Published in:

01-12-2013 | News item

Project aims to advance vaccine benefit:risk assessment in Europe

Published in: Reactions Weekly | Issue 1/2013

Excerpt

The EMA, in collaboration with the Innovative Medicines Initiative (IMI) and the European Centre for Disease Prevention and Control (ECDC), has begun an initiative to monitor and communicate the benefits and risks of vaccines post-approval in the greater European region. …

EMA. Launch of European project for monitoring benefits and risks of vaccines throughout their lifecycle. Internet Document : 26 Nov 2013. Available from: URL: http://www.ema.europa.eu

Title: Project aims to advance vaccine benefit:risk assessment in Europe
Publication date: 01-12-2013
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2013
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-7677-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Project aims to advance vaccine benefit:risk assessment in Europe

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Doxorubicin

Natalizumab

Dabigatran etexilate/dexlansoprazole interaction

Levetiracetam/phenytoin

Codeine phosphate/ramipril

Methotrexate